series-a
Stage
1
Investors
About
Pear Bio is a computational biology company that has developed a functional precision medicine platform to optimize clinical cancer care and drug development. The platform uses microphysiological systems and 3D computer vision to measure cancer progression over time by culturing patient tumor samples and immune cells to test potential treatment options and combinations ex vivo.
Explore Pear Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.